Literature DB >> 1402666

A third tal-1 promoter is specifically used in human T cell leukemias.

O Bernard1, O Azogui, N Lecointe, F Mugneret, R Berger, C J Larsen, D Mathieu-Mahul.   

Abstract

A common feature of T cell acute lymphoblastic leukemias (T-ALLs) is the presence of structural alteration of the 5' part of the tal-1 locus, localized on chromosomal band 1p32. These alterations consist of either a t(1;14)(p32;q11) chromosomal translocation (3% of T-ALLs) or tald submicroscopic deletion (12-25% additional T-ALLs). We have characterized a case of T-ALL with t(1;14)(p32;q11) in which, unlike the majority of t(1;14), the recombination with the T cell receptor delta elements affected the 3' side of the tal-1 locus. In this case, tal-1 transcription is initiated from a promoter located within the fourth exon similarly to the DU 528 cell line. In a T-ALL bearing a t(1;14) affecting the 5' part of tal-1, two types of tal-1 transcripts were observed, namely those probably initiated from the D delta region juxtaposed to tal-1 by the translocation, and those from the exon 4 promoter. It is interesting that this exon 4 promotion was also found in leukemic T cell lines and T-ALL samples without apparent tal-1 genomic alteration. In contrast, no transcript initiated from the exon 4 promoter was found in T-ALL with tald1 or tald2 deletion. In these cells, tal-1 is expressed via SIL-tal-1 fused transcripts. Finally, this exon 4 initiation was detected neither in normal bone marrow, nor in malignant cells from the erythroid/megakaryocytic lineages. Taken as a whole, these data suggest that the exon 4 promoter is specifically active in T cell lineage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402666      PMCID: PMC2119401          DOI: 10.1084/jem.176.4.919

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Genetic alterations in leukemia: events on a grand scale.

Authors:  K Shannon
Journal:  Blood       Date:  1992-07-01       Impact factor: 22.113

2.  Studies on the human T cell receptor alpha/beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segments.

Authors:  S Roman-Roman; L Ferradini; J Azocar; C Genevée; T Hercend; F Triebel
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

3.  Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain.

Authors:  E Y Loh; J F Elliott; S Cwirla; L L Lanier; M M Davis
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  The structure, rearrangement and expression of D beta gene segments of the murine T-cell antigen receptor.

Authors:  G Siu; M Kronenberg; E Strauss; R Haars; T W Mak; L Hood
Journal:  Nature       Date:  1984 Sep 27-Oct 3       Impact factor: 49.962

6.  The translocation (1;14)(p34;q11) in human T-cell leukemia: chromosome breakage 25 kilobase pairs downstream of the TAL1 protooncogene.

Authors:  Y Xia; L Brown; J T Tsan; C Y Yang; M J Siciliano; W M Crist; A J Carroll; R Baer
Journal:  Genes Chromosomes Cancer       Date:  1992-04       Impact factor: 5.006

7.  TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.

Authors:  Y Xia; L Brown; C Y Yang; J T Tsan; M J Siciliano; R Espinosa; M M Le Beau; R J Baer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

8.  c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).

Authors:  T J Fitzgerald; G A Neale; S C Raimondi; R M Goorha
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

9.  Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma.

Authors:  L R Finger; J Kagan; G Christopher; J Kurtzberg; M S Hershfield; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; G H Reaman; H N Sather; G D Hammond; I R Kirsch
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

View more
  10 in total

1.  Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1.

Authors:  J T Cheng; M H Cobb; R Baer
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

Review 2.  Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL.

Authors:  Adrian Rivera-Reyes; Katharina E Hayer; Craig H Bassing
Journal:  Trends Mol Med       Date:  2016-10-27       Impact factor: 11.951

Review 3.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

4.  Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade.

Authors:  G L Condorelli; A Tocci; R Botta; F Facchiano; U Testa; L Vitelli; M Valtieri; C M Croce; C Peschle
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

Review 5.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

6.  Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.

Authors:  B Patel; Y Kang; K Cui; M Litt; M S J Riberio; C Deng; T Salz; S Casada; X Fu; Y Qiu; K Zhao; S Huang
Journal:  Leukemia       Date:  2013-05-23       Impact factor: 11.528

7.  Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA Sequencing.

Authors:  Jayne Y Hehir-Kwa; Marco J Koudijs; Eugene T P Verwiel; Lennart A Kester; Marc van Tuil; Eric Strengman; Arjan Buijs; Mariëtte E G Kranendonk; Laura S Hiemcke-Jiwa; Valerie de Haas; Ellen van de Geer; Wendy de Leng; Jasper van der Lugt; Philip Lijnzaad; Frank C P Holstege; Patrick Kemmeren; Bastiaan B J Tops
Journal:  JCO Precis Oncol       Date:  2022-01

8.  Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

Authors:  K Leroy-Viard; M A Vinit; N Lecointe; H Jouault; U Hibner; P H Roméo; D Mathieu-Mahul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

9.  Distinct functions for different scl isoforms in zebrafish primitive and definitive hematopoiesis.

Authors:  Feng Qian; Fenghua Zhen; Jin Xu; Mei Huang; Wanyu Li; Zilong Wen
Journal:  PLoS Biol       Date:  2007-05       Impact factor: 8.029

10.  Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.

Authors:  Ying Li; Ziwei Liao; Huacheng Luo; Aissa Benyoucef; Yuanyuan Kang; Qian Lai; Sinisa Dovat; Barbara Miller; Iouri Chepelev; Yangqiu Li; Keji Zhao; Marjorie Brand; Suming Huang
Journal:  Nucleic Acids Res       Date:  2020-04-06       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.